| OALBC0104 | National roll out of community HIV screening among key populations in Indonesia: assessment of early results | Oral abstract session with live Q&A | HIV self-testing |
| EPC351 | National HIV Testing Week: an effective tool for increasing HIV testing at scale in key populations during and beyond COVID-19 | E-poster | HIV testing with virtual and/or digital support |
| PESAC10 | National and regional rates of hospitalizations and in-hospital mortality for opportunistic infections for people with HIV in the United States, 2012-2018 | Poster exhibition | Epidemiology of AIDS events (e.g., AIDS-related opportunistic infections and cancers) |
| EPA061 | Nanoparticle delivery of romidepsin to reverse HIV latency | E-poster | Strategies to reduce/eliminate viral reservoirs |
| PEMOD53 | 'My attitude towards my own journey changed the way others see me and treat me': insights from male peers living with HIV on challenging and changing stigma | Poster exhibition | Confronting stigma: Lessons learned |
| EPA037 | MVA/Protein HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques | E-poster | Novel vectors, adjuvants and strategies |
| EPC473 | Multiple strategies are needed for enrolling individuals in randomized COVID-19 trials. Lessons learned from a home base postexposure trial in Argentina | E-poster | COVID-19 prevention |
| EPE174 | Multi-month dispensing and use of dolutegravir associated with better viral suppression among children in Nigeria | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
| EPA045 | Multi-modal statistical analysis strategies identify biomarkers of cell-associated Gag RNA expression levels during ART | E-poster | Host cellular factors and viral mechanisms of HIV/SIV persistence and latency |
| EPB134 | Multi-medicine use and potential drug'drug interactions among people living with HIV on antiretroviral therapy in Australia | E-poster | Drug-drug interaction (DDI) |